⌘K

Login Start Free

Home/Filings/4/0001104659-22-068508

4//SEC Filing

MARGOLIN YAEL 4

Accession 0001104659-22-068508

CIK 0001811764other

View on SEC.gov Company Profile

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 4:04 PM ET

Size

5.3 KB

Accession

0001104659-22-068508

Insider Transaction Report

Form 4

Period: 2022-06-02

POINT Biopharma Global Inc.PNT

Director

Transactions

Award
Stock Option (Right to Buy)
2022-06-02+25,614→ 25,614 total
Exercise: $8.31Exp: 2028-06-02→ Common Stock (25,614 underlying)

Footnotes (1)

[F1]The option will vest 100% on the first anniversary of the grant date.

Documents

1 file

4
tm2217697-2_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

POINT Biopharma Global Inc.

CIK 0001811764

Entity typeother

Related Parties

1

filerCIK 0001868637

Filing Metadata

Form type: 4
Filed: Jun 5, 8:00 PM ET
Accepted: Jun 6, 4:04 PM ET
Size: 5.3 KB

View on SEC.gov